Attachment A 36C25221Q0585.xlsx
XLSX spreadsheet 27 KB Posted
- Attached to
- 6505--Blood and Blood Products IL Group
- Solicitation number
- 36C25221Q0585
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C25221Q0585.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1
| IL GROUP | 10/1/21 - 9/30/2022 | 10/1/22 - 9/30/2023 | 10/1/23 - 9/30/2024 | 10/1/24 - 9/30/2025 | 10/1/25 - 9/30/2026 | Estimated Annual Quantities | ||||||||||||
| Blood Components and Product Modifications: | Qty | Unit Price | Estimated Total | Qty | Unit Price | Estimated Total | Qty | Unit Price | Estimated Total | Qty | Unit Price | Estimated Total | Qty | Unit Price | Estimated Total | Jesse Brown | FHCC | Hines |
| Leukoreduced Red Blood Cells | 3790 | $ - 0 | 3790 | $ - 0 | 3790 | $ - 0 | 3790 | $ - 0 | 3790 | $ - 0 | 1700 | 450 | 1640 | |||||
| Fresh Frozen Plasma | 576 | $ - 0 | 576 | $ - 0 | 576 | $ - 0 | 576 | $ - 0 | 576 | $ - 0 | 230 | 46 | 300 | |||||
| Apheresis Platelets | 335 | $ - 0 | 335 | $ - 0 | 335 | $ - 0 | 335 | $ - 0 | 335 | $ - 0 | 105 | 30 | 200 | |||||
| Pathogen Reduced Platelet Apheresis | 168 | $ - 0 | 168 | $ - 0 | 168 | $ - 0 | 168 | $ - 0 | 168 | $ - 0 | 53 | 15 | 100 | |||||
| Large Volume Delayed Sampling Platelet Apheresis | 167 | $ - 0 | 167 | $ - 0 | 167 | $ - 0 | 167 | $ - 0 | 167 | $ - 0 | 52 | 15 | 100 | |||||
| Variable Content Platelet Apheresis | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| HPA Matched Platelet Apheresis | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Cryopreciptate, Random | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Cryopreciptate, Pooled | 104 | $ - 0 | 104 | $ - 0 | 104 | $ - 0 | 104 | $ - 0 | 104 | $ - 0 | 50 | 4 | 50 | |||||
| Whole Blood | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Leukoreduced Whole Blood | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Liquid Plasma | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Cryoprecipitate Reduced Plasma (Cryo-poor) | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Granulocytes | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| LRBCD (Pediatric Red Cell Set): 3/set | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| LRBCD (Pediatric Red Cell Set): 6/set | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| LRBCD (Pediatric Red Cell Set): 9/set | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| LSDPN (Neonate Platelet Aliquot): Single Unit | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| FFPD (Pediatric Fresh Frozen Plasma Set): 6/set | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Attached Empty Pediatric Bag Set: 3/set | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Attached Empty Pediatric Bag Set: 6/set | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Attached Empty Pediatric Bag Set: 9/set | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Irradiation (per uit) | 740 | $ - 0 | 740 | $ - 0 | 740 | $ - 0 | 740 | $ - 0 | 740 | $ - 0 | 330 | 10 | 400 | |||||
| CMV Screening (per unit) | 25 | $ - 0 | 25 | $ - 0 | 25 | $ - 0 | 25 | $ - 0 | 25 | $ - 0 | 1 | 1 | 23 | |||||
| HLA Matching (per unit) | 21 | $ - 0 | 21 | $ - 0 | 21 | $ - 0 | 21 | $ - 0 | 21 | $ - 0 | 20 | 0 | 1 | |||||
| Volume reduction (per unit) | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Washing (per unit) | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Divided (per unit) | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Deglycerized (per unit) | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Restocking Fee | 100 | $ - 0 | 100 | $ - 0 | 100 | $ - 0 | 100 | $ - 0 | 100 | $ - 0 | 30 | 20 | 50 | |||||
| Autologous Donation Surcharge | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Directed Donation Surcharge | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 | |||||
| Blood Import Fee | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | 0 | 0 |
Estimated Total $ - 0 $ - 0 $ - 0 $ - 0 $ - 0
Reference Laboratory Testing (IRL) and Miscellaneous VISN Total Unit Price Estimated Total VISN Total Unit Price Estimated Total VISN Total Unit Price Estimated Total VISN Total Unit Price Estimated Total VISN Total Unit Price Estimated Total
| 10/1/21 - 9/30/2022 | 10/1/22 - 9/30/2023 | 10/1/23 - 9/30/2024 | 10/1/24 - 9/30/2025 | 10/1/25 - 9/30/2026 | ||||||
| ABO and Rh | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 |
| ABO Antibody Titer | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| ADAMTS13 Activity | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| ADAMTS13 Antibody | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| ADAMTS13 Inhibitor | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| ADAMTS13 Sequence Analysis | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Alloadsorption (per adsorption) | 15 | $ - 0 | 15 | $ - 0 | 15 | $ - 0 | 15 | $ - 0 | 15 | $ - 0 |
| Antibody Adsorption RESt/WARM | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 |
| Antibody Identification Panel - Saline IAT | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 |
| Antibody Identification Panel - PEG IAT | 6 | $ - 0 | 6 | $ - 0 | 6 | $ - 0 | 6 | $ - 0 | 6 | $ - 0 |
| Antibody Identification Panel - LISS IAT | 6 | $ - 0 | 6 | $ - 0 | 6 | $ - 0 | 6 | $ - 0 | 6 | $ - 0 |
| Antibody Identification Panel - GEL IAT | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 |
| Antibody Identification Panel - Prewarm IAT | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Antibody Identification Panel - Ficin IAT | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Antibody Identification Panel - DTT/AET IAT | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Antibody Identification Panel - Chlorquine/EGA IAT | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Antibody Screen - Saline IAT | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 |
| Antibody Screen - PEG IAT | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 |
| Antibody Screen - LISS IAT | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 |
| Antibody Screen - GEL IAT | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 |
| Antibody Screen -Prewarm IAT | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 |
| Antibody Screen - Ficin IAT | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 |
| Antibody Screen - DTT/AET IAT | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 |
| Antibody Screen - Chlorquine/EGA IAT | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 |
| Antibody Titration | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Antigen Typing (other than Rh) | 45 | $ - 0 | 45 | $ - 0 | 45 | $ - 0 | 45 | $ - 0 | 45 | $ - 0 |
| Antigen Typing (Rare) | 3 | $ - 0 | 3 | $ - 0 | 3 | $ - 0 | 3 | $ - 0 | 3 | $ - 0 |
| Autoadsorption - ZZAP (per adsorption) | 30 | $ - 0 | 30 | $ - 0 | 30 | $ - 0 | 30 | $ - 0 | 30 | $ - 0 |
| Chemical Treatment of Serum (2-Mercaptoethanol Treated Serum) | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 |
| Cold Agglutinin Panel | 4 | $ - 0 | 4 | $ - 0 | 4 | $ - 0 | 4 | $ - 0 | 4 | $ - 0 |
| Compatibility Screen (Crossmatch) | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Compatiblity Screen with Alloadsorbed Serum | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| DAT Negative Hemolytic Anemia Evaluation | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 |
| Direct Antiglobulin Test - Polyreactive AHG | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 |
| Direct Antiglobulin Test - Monospecific Evaluation | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 |
| Direct Antiglobulin Test IgA Detection | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 |
| Donath Landsteiner | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Drug Dependent RBC Antibody Study | 3 | $ - 0 | 3 | $ - 0 | 3 | $ - 0 | 3 | $ - 0 | 3 | $ - 0 |
| Elution (per elution) | 25 | $ - 0 | 25 | $ - 0 | 25 | $ - 0 | 25 | $ - 0 | 25 | $ - 0 |
| Heparin-Induced Thrombocytopenia Evaluation: PF4 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Heparin-Induced Thombocytopenia Evaluation: Serotonin Release Assay | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| HLA Antibody Identification Class I High Resolution | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| HLA Antibody Low Resolution | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| HLA Antibody Screen | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Neutralization | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Neutrophil Antibody | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Partial RhD Anaylsis (molecular) | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 |
| Partial RhD Screening (serology) | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 |
| Platelet Crossmatch | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 | 2 | $ - 0 |
| Platelet Transfusion Refractory (PTR) Panel | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 |
| Post Transfusion Purpura (PTP) Panel | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Rare Cell Rule Out Panel | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 |
| Red Cell Rule-Out Panel (any method) | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 | 35 | $ - 0 |
| Red Cell Genotyping Panel (44 antigens) | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 |
| Red Cell Genotyping STAT Panel (24 antigens) | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 |
| Rh Phenotype (D,C,E,c,e) | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Screen Units: 1 Antigen Screened Unit | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Screen Units: 2 Antigen Screened Unit | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Screen Units: 3 Antigen Screened Unit | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Screen Units: 4 Antigen Screened Unit | 3 | $ - 0 | 3 | $ - 0 | 3 | $ - 0 | 3 | $ - 0 | 3 | $ - 0 |
| Screen Units: 5 Antigen Screened Unit | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 |
| Screen Units: 6 Antigen Screened Unit | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Screen Units: 7 Antigen Screened Unit | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Screen Units: 8 Antigen Screened Unit | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Screen Units: 9 Antigen Screened Unit | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Screen Units: 10 or more Antigen Screened Unit | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Screened Unit - Hemoglobin S | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Screened Unit - Molecular | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Screened Unit - Rare Antigen | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Selected Cell Rule-Out Panel - Saline IAT | 21 | $ - 0 | 21 | $ - 0 | 21 | $ - 0 | 21 | $ - 0 | 21 | $ - 0 |
| Selected Cell Rule-Out Panel - PEG IAT | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Selected Cell Rule-Out Panel - LISS IAT | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Selected Cell Rule-Out Panel - GEL IAT | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 |
| Selected Cell Rule-Out Panel - Prewarm IAT | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 | 5 | $ - 0 |
| Selected Cell Rule-Out Panel - Ficin IAT | 4 | $ - 0 | 4 | $ - 0 | 4 | $ - 0 | 4 | $ - 0 | 4 | $ - 0 |
| Selected Cell Rule-Out Panel - DTT/AET IAT | 4 | $ - 0 | 4 | $ - 0 | 4 | $ - 0 | 4 | $ - 0 | 4 | $ - 0 |
| Selected Cell Rule-Out Panel - Chlorquie/EGA IAT | 4 | $ - 0 | 4 | $ - 0 | 4 | $ - 0 | 4 | $ - 0 | 4 | $ - 0 |
| Selected Cell Screen - Saline IAT | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 | 10 | $ - 0 |
| Selected Cell Screen - PEG IAT | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 |
| Selected Cell Screen - LISS IAT | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 |
| Selected Cell Screen - GEL IAT | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 |
| Selected Cell Screen - Prewarm IAT | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 |
| Selected Cell Screen - Ficin IAT | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 |
| Selected Cell Screen - DTT/AET IAT | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 | 8 | $ - 0 |
| Selected Cell Screen - Chlorquine/EGA IAT | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Thermal Amplitude Study | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Transfusion Related Acute Lung Injury (TRALI) Workup | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Cell Separation: Reticulocyte Preparation/Microhematocrit | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Platelet Antigen Genotyping | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| D Antigen Typing | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Cell Separation: Hypotonic Wash | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
| Weak RhD Analysis | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 | 1 | $ - 0 |
| COVID19 Convalescent Plasma (CCP) **** | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 | 0 | $ - 0 |
IRL & MISC ESTIMATED TOTAL $ - 0 $ - 0 $ - 0 $ - 0 $ - 0
ESTIMATED ANNUAL TOTAL FOR HINES, JESSE BROWN, AND LOVEL $ - 0 $ - 0 $ - 0 $ - 0 $ - 0
$ - 0
File details come from the government source that posted it. Updated .